drugset / Trial / NCT06321705

Safety and Efficacy of Continued CS1 Treatment of Patients With Pulmonary Arterial Hypertension

NCT06321705 ↗

Summary

CS1-004 will be an extension of the CS1-003 Study. The primary objective of the CS1-004 study is to evaluate long-term safety and tolerability of continued treatment with CS1.

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject CS1 Unknown 480 mg —
Subject CS1 Unknown 960 mg —
Subject CS1 Unknown 1920 mg —